1. Home
  2. SWAG vs PMN Comparison

SWAG vs PMN Comparison

Compare SWAG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

N/A

Current Price

$1.70

Market Cap

38.2M

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$17.70

Market Cap

34.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWAG
PMN
Founded
1994
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Advertising
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
34.6M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SWAG
PMN
Price
$1.70
$17.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
30.7K
50.8K
Earning Date
03-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
110.28
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.29
52 Week High
$3.50
$27.40

Technical Indicators

Market Signals
Indicator
SWAG
PMN
Relative Strength Index (RSI) 45.03 45.78
Support Level $1.64 $0.42
Resistance Level $1.89 $19.85
Average True Range (ATR) 0.11 2.61
MACD -0.00 -0.84
Stochastic Oscillator 44.83 12.32

Price Performance

Historical Comparison
SWAG
PMN

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: